Fast, accurate diagnosis is key to developing a treatment plan for any condition and disease—and flu is no exception. Without the right diagnostic tools, however, it is very hard to distinguish flu from other viral or bacterial causes of respiratory illnesses. And if it's an influenza-like illness (ILI), it won't necessary respond to antivirals used to treat flu.
A patient with symptoms of respiratory illness who tests negative for COVID-19 may have still have the flu—which is why flu testing remains important, especially among groups receiving fewer vaccinations than last year, including children and pregnant women.¹
Henry Schein Medical offers a robust portfolio of flu tests that can be administered and read at the point of care. With rapid results in minutes, rather than hours and days, it may be possible for you to:
Our flu test portfolio includes readers and lateral flow options.
This fast and accurate solution streamlines the point-of-care (POC) diagnostic workflow and allows providers to quickly review patient results and determine the appropriate treatment in a single consultation. The system can help detect infectious diseases such as influenza A and B, respiratory syncytial virus (RSV), and group A strep while the patient is still on site, which can enable faster decision-making for an earlier intervention opportunity.
Accurately reads and interprets lateral flow tests in just seconds, delivering automated, objective results in any health-care setting. It is a camerabased instrument that will detect the presence of, and identify a completed lateral flow assay, analyze the intensity of the test and control line, and display the results (positive, negative, or invalid) on the color touch screen.
The Acucy™ Influenza A&B Test on the Acucy™ System provides clinicians flexibility in workflow and accurate, standardized results for improved patient care.
Intended for the qualitative detection of influenza type A and type B nucleoprotein antigens directly from nasal and nasopharyngeal swab specimens from patients with signs and symptoms of respiratory infection.
An immunoassay for detecting influenza types A and B. Three simple steps with results in 10 minutes or less. Color-coded procedure card helps demonstrate each step of test. Kit contains positive and negative controls, and stores at room temperature.
An in vitro, rapid qualitative test that detects influenza type A and B nucleoprotein antigens directly from nasal swab, nasopharyngeal swab, and nasopharyngeal aspirate/wash specimens obtained from patients with signs and symptoms of respiratory infection.